Анализа уретка серума за нивое Hcy, HMGB1 и TLR4 и поларизацију мононуклеарних макрофага код акутног церебралног инфаркта: Нивои серума Hcy, HMGB1 и TLR4 и поляризација мононуклеарних макрофага код АЦИ
Scindeks Asistent Scindeks Asistent — sistem za ozbiljne časopise i one koji to žele da postanu
PDF (engleski)

Sažetak

[Objective] To explore the correlations between homocysteine (Hcy), high mobility group protein B1 (HMGB1), and Toll-like receptor 4 (TLR4) levels and the polarization of mononuclear macrophages among individuals who were admitted with acute cerebral infarction (ACI).

[Methods] The case group was made up of 214 ACI patients who were admitted to the hospital between August 2022 and August 2024, whereas the control group was made up of 100 healthy people who had physicals over the same time frame.  A comparison was made between the two groups' admission serum Hcy, HMGB1, and TLR4 levels. The polarization conditions of the mononuclear macrophages in the two groups were compared [proportion of M1-type cells, proportion of M2-type cells, M1/M2 ratio, M1-type polarization markers (interleukin-1β, tumor necrosis factor-α), and M2-type polarization markers (interleukin-10, transforming growth factor-β)]. to investigate the connections between the polarization of mononuclear macrophages and the levels of Hcy, HMGB1, and TLR4 in ACI patients, as well as the associations between these levels and the prognosis of ACI patients. Serum levels of Hcy, HMGB1, and TLR4 were compared between the ACI patients who were split into groups with excellent and poor prognoses. The prognostic efficacy of Hcy, HMGB1, and TLR4 for the prognosis of ACI patients was evaluated using receiver operating characteristic (ROC) curves.

[Results] Serum Hcy, HMGB1, and TLR4 levels in the case group were considerably higher (P<0.05) than those in the control group. Interleukin-1β and tumor necrosis factor-α levels, the M1/M2 ratio, and the percentage of M1-type cells were all considerably greater (P<0.05) in the case group compared to the control group, although transforming growth factor-β and interleukin-10 levels were significantly lower (P<0.05). Serum Hcy, HMGB1, and TLR4 levels in ACI patients were found to be negatively correlated with interleukin-10 and transforming growth factor-β (P<0.05) and positively correlated with the proportion of M1-type cells, the M1/M2 ratio, and the levels of interleukin-1β and tumor necrosis factor-α (P<0.05), according to the results of the Pearson correlation analysis. Serum Hcy, HMGB1, and TLR4 levels were substantially higher (P<0.05) in the poor prognosis group than in the good prognosis group.  With area under the curve (AUC) values of 80.00%, 77.80%, and 0.840 for sensitivity, specificity, and AUC, respectively. The ROC curve analysis showed that the combined prediction of Hcy, HMGB1, and TLR4 levels had a comparatively high efficacy in predicting the prognosis of ACI patients.

[Conclusion] Patients with ACI had elevated levels of Hcy, HMGB1, and TLR4 expression in their peripheral blood. These levels are anticipated to be biomarkers for the clinical diagnosis and treatment of ACI and are strongly correlated with the polarization of mononuclear macrophages and patient prognosis.

Ključne reči

Array
Array
Array
Array
Array
Array
DOI: 10.5937/jomb0-61703

Reference

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Preuzimanja

Podaci o preuzimanju još nisu dostupni.